Cognex Corporation (NASDAQ:CGNX) Receives $42.50 Average Target Price from Analysts

Cognex Corporation (NASDAQ:CGNX) has been assigned an average rating of “Moderate Buy” from the sixteen analysts that are currently covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, seven have assigned a hold recommendation, seven have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month target price among analysts that have issued ratings on the stock in the last year is $43.0714.

CGNX has been the topic of a number of analyst reports. Robert W. Baird increased their price target on shares of Cognex from $30.00 to $32.00 and gave the company a “neutral” rating in a research report on Monday, June 16th. The Goldman Sachs Group raised their target price on shares of Cognex from $36.00 to $40.00 and gave the stock a “sell” rating in a report on Tuesday. UBS Group raised their target price on shares of Cognex from $53.00 to $58.00 and gave the stock a “buy” rating in a report on Friday, August 1st. JPMorgan Chase & Co. began coverage on shares of Cognex in a report on Monday. They set a “neutral” rating and a $45.00 target price on the stock. Finally, DA Davidson raised their target price on shares of Cognex from $32.00 to $35.00 and gave the stock a “neutral” rating in a report on Monday, August 4th.

Cognex Price Performance

Shares of NASDAQ:CGNX opened at $46.19 on Tuesday. The company has a market capitalization of $7.76 billion, a price-to-earnings ratio of 65.06 and a beta of 1.50. The firm’s 50 day simple moving average is $40.73 and its 200 day simple moving average is $33.37. Cognex has a fifty-two week low of $22.67 and a fifty-two week high of $46.38.

Cognex (NASDAQ:CGNX) last announced its quarterly earnings results on Wednesday, July 30th. The scientific and technical instruments company reported $0.25 earnings per share for the quarter, beating analysts’ consensus estimates of $0.23 by $0.02. The business had revenue of $249.09 million for the quarter, compared to the consensus estimate of $246.70 million. Cognex had a net margin of 13.13% and a return on equity of 6.65%. Cognex’s revenue for the quarter was up 4.2% on a year-over-year basis. During the same period last year, the company posted $0.23 EPS. Cognex has set its Q3 2025 guidance at 0.240-0.290 EPS. Equities research analysts expect that Cognex will post 0.61 earnings per share for the current year.

Cognex Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, August 28th. Shareholders of record on Thursday, August 14th were issued a dividend of $0.08 per share. This represents a $0.32 annualized dividend and a yield of 0.7%. The ex-dividend date was Thursday, August 14th. Cognex’s dividend payout ratio (DPR) is 45.07%.

Insider Buying and Selling

In other Cognex news, EVP Sheila Marie Dipalma sold 2,000 shares of the firm’s stock in a transaction that occurred on Monday, September 8th. The shares were sold at an average price of $45.03, for a total transaction of $90,060.00. Following the sale, the executive vice president directly owned 6,582 shares in the company, valued at approximately $296,387.46. This trade represents a 23.30% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Company insiders own 1.60% of the company’s stock.

Hedge Funds Weigh In On Cognex

Several hedge funds have recently made changes to their positions in the business. Northwestern Mutual Wealth Management Co. grew its stake in shares of Cognex by 12.9% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 2,132 shares of the scientific and technical instruments company’s stock worth $68,000 after acquiring an additional 243 shares in the last quarter. First Horizon Advisors Inc. grew its stake in shares of Cognex by 10.6% during the 2nd quarter. First Horizon Advisors Inc. now owns 2,788 shares of the scientific and technical instruments company’s stock worth $88,000 after acquiring an additional 268 shares in the last quarter. Centaurus Financial Inc. grew its stake in shares of Cognex by 8.1% during the 2nd quarter. Centaurus Financial Inc. now owns 4,021 shares of the scientific and technical instruments company’s stock worth $128,000 after acquiring an additional 303 shares in the last quarter. Farther Finance Advisors LLC grew its stake in shares of Cognex by 31.5% during the 2nd quarter. Farther Finance Advisors LLC now owns 1,277 shares of the scientific and technical instruments company’s stock worth $40,000 after acquiring an additional 306 shares in the last quarter. Finally, Manchester Capital Management LLC grew its stake in shares of Cognex by 11.5% during the 2nd quarter. Manchester Capital Management LLC now owns 3,067 shares of the scientific and technical instruments company’s stock worth $97,000 after acquiring an additional 317 shares in the last quarter. 88.12% of the stock is owned by institutional investors.

Cognex Company Profile

Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.